Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
05/31/2023 | MACROGENICS INC | MGNX | Grant | Restricted Stock Unit | 4.5k | $0.00 | $0 | | 05/31/2023 |
05/31/2023 | MACROGENICS INC | MGNX | Grant | Stock Option (right to buy) | 19k | $4.67 | $88.7k | | 05/31/2023 |
05/24/2023 | Dyne Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 24.9k | $13.49 | $335.9k | | 05/24/2023 |
11/30/2022 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Disposition | Stock Option (Right to Buy) | 4.7k | $20.83 | $97.7k | | 11/30/2022 |
11/30/2022 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Disposition | Stock Option (Right to Buy) | 9.4k | $12.00 | $112.5k | | 11/30/2022 |
11/30/2022 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Other | Common Stock | 1.8k | $0.00 | $0 | By Hurwitz/Lichtenfeld Revocable Trust | 11/30/2022 |
11/30/2022 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Other | Common Stock | 25.7k | $0.00 | $0 | | 11/30/2022 |
11/30/2022 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Disposition | Stock Option (Right to Buy) | 14k | $2.17 | $30.4k | | 11/30/2022 |
11/30/2022 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Disposition | Stock Option (Right to Buy) | 12k | $4.72 | $56.6k | | 11/30/2022 |
11/30/2022 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Disposition | Stock Option (Right to Buy) | 10k | $3.02 | $30.2k | | 11/30/2022 |
11/30/2022 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Disposition | Stock Option (Right to Buy) | 10k | $6.90 | $69k | | 11/30/2022 |
11/30/2022 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Disposition | Stock Option (Right to Buy) | 10k | $4.25 | $42.5k | | 11/30/2022 |
11/30/2022 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Disposition | Stock Option (Right to Buy) | 8k | $7.75 | $62k | | 11/30/2022 |
11/30/2022 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Disposition | Stock Option (Right to Buy) | 6.2k | $16.06 | $99.6k | | 11/30/2022 |
06/03/2022 | Dyne Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 19.6k | $4.58 | $89.7k | | 06/03/2022 |
05/19/2022 | MACROGENICS INC | MGNX | Grant | Stock Option (right to buy) | 18k | $3.90 | $70.2k | | 05/19/2022 |
11/30/2021 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Grant | Stock Option (right to buy) | 14k | $2.17 | $30.4k | | 11/30/2021 |
05/26/2021 | Dyne Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 19.6k | $19.56 | $383.3k | | 05/26/2021 |
05/13/2021 | MACROGENICS INC | MGNX | Grant | Stock Option (right to buy) | 15k | $28.88 | $433.2k | | 05/13/2021 |
12/16/2020 | APPLIED GENETIC TECHNOLOGIES CORP | AGTC | Grant | Stock Option (right to buy) | 12k | $4.72 | $56.6k | | 12/16/2020 |
09/21/2020 | Dyne Therapeutics, Inc. | | Conversion | Common Stock | 245.3k | $0.00 | $0 | See footnote | 07/31/2020 |
09/21/2020 | Dyne Therapeutics, Inc. | | Conversion | Common Stock | 91.1k | $0.00 | $0 | See footnote | 07/31/2020 |
09/21/2020 | Dyne Therapeutics, Inc. | | Conversion | Common Stock | 4.6M | $0.00 | $0 | See footnote | 07/31/2020 |
09/21/2020 | Dyne Therapeutics, Inc. | | Conversion | Series A Preferred Stock | 14M | $0.00 | $0 | See footnote | 07/31/2020 |
09/21/2020 | Dyne Therapeutics, Inc. | | Conversion | Series A Preferred Stock | 743.1k | $0.00 | $0 | See footnote | 07/31/2020 |
09/21/2020 | Dyne Therapeutics, Inc. | | Conversion | Series A Preferred Stock | 275.9k | $0.00 | $0 | See footnote | 07/31/2020 |
09/21/2020 | Dyne Therapeutics, Inc. | | Conversion | Series B Preferred Stock | 1.3M | $0.00 | $0 | See footnote | 07/31/2020 |
09/21/2020 | Dyne Therapeutics, Inc. | | Conversion | Series B Preferred Stock | 70.5k | $0.00 | $0 | See footnote | 07/31/2020 |
09/21/2020 | Dyne Therapeutics, Inc. | | Conversion | Series B Preferred Stock | 26.2k | $0.00 | $0 | See footnote | 07/31/2020 |
08/07/2020 | Dyne Therapeutics, Inc. | | Purchase | Series B Preferred Stock | 1.3M | $2.81 | $3.7M | See footnote | 07/31/2020 |
08/07/2020 | Dyne Therapeutics, Inc. | | Purchase | Series B Preferred Stock | 70.5k | $2.81 | $198.2k | See footnote | 07/31/2020 |
08/07/2020 | Dyne Therapeutics, Inc. | | Purchase | Series B Preferred Stock | 26.2k | $2.81 | $73.6k | See footnote | 07/31/2020 |
07/31/2020 | Dyne Therapeutics, Inc. | | Purchase | Series A Preferred Stock | 4.9M | $1.00 | $4.9M | See footnote | 07/31/2020 |
07/31/2020 | Dyne Therapeutics, Inc. | | Purchase | Series A Preferred Stock | 260.1k | $1.00 | $260.1k | See footnote | 07/31/2020 |
07/31/2020 | Dyne Therapeutics, Inc. | | Purchase | Series A Preferred Stock | 96.6k | $1.00 | $96.6k | See footnote | 07/31/2020 |
|